0001453687-22-000129.txt : 20220906 0001453687-22-000129.hdr.sgml : 20220906 20220906203741 ACCESSION NUMBER: 0001453687-22-000129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220901 FILED AS OF DATE: 20220906 DATE AS OF CHANGE: 20220906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brunn Carsten CENTRAL INDEX KEY: 0001760229 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37798 FILM NUMBER: 221229667 MAIL ADDRESS: STREET 1: C/O SELECTA BIOSCIENCES, INC. STREET 2: 480 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SELECTA BIOSCIENCES INC CENTRAL INDEX KEY: 0001453687 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 GROVE STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-923-1400 MAIL ADDRESS: STREET 1: 65 GROVE STREET CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 wf-form4_166251104851877.xml FORM 4 X0306 4 2022-09-01 0 0001453687 SELECTA BIOSCIENCES INC SELB 0001760229 Brunn Carsten C/O SELECTA BIOSCIENCES, INC. 65 GROVE STREET WATERTOWN MA 02472 1 1 0 0 President and CEO Common Stock 2022-09-01 4 M 0 10937 0 A 545327 D Common Stock 2022-09-02 4 S 0 4768 1.8478 D 540559 D Restricted Stock Units 2022-09-01 4 M 0 10937 0 D Common Stock 10937.0 10938 D Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.825 to $1.855. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Each restricted stock unit represents a contingent right to receive one share of common stock. This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date. /s/ Matthew Bartholomae, Attorney-in-Fact for Carsten Brunn 2022-09-06